Orthofix Medical Inc. - Common Stock (OFIX)

CUSIP: 68752M108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
39,581,465
Total 13F shares
35,152,622
Share change
-55,584
Total reported value
$532,914,571
Price per share
$15.16
Number of holders
142
Value change
-$494,427
Number of buys
55
Number of sells
76

Quarterly Holders Quick Answers

What is CUSIP 68752M108?
CUSIP 68752M108 identifies OFIX - Orthofix Medical Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OFIX - Orthofix Medical Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Engine Capital Management, LP
13F
Company
11%
4,252,921
$62,262,763 30 Sep 2025
13F
ENGINE CAPITAL, L.P.
13D/G
Engine Capital Management, LP
11%
4,251,671
$60,331,211 +$8,846,670 07 May 2025
Rubric Capital Management LP
13F
Company
9.4%
3,721,715
$54,485,908 30 Sep 2025
13F
PARADIGM CAPITAL MANAGEMENT INC/NY
13F
Company
8.4%
3,344,500
$48,963,480 30 Sep 2025
13F
BlackRock, Inc.
13F 13D/G
Company
7.7%
from 13D/G
3,137,570
$45,934,026 30 Sep 2025
Juniper Investment Company, LLC
13F
Company
7.2%
2,847,055
$41,680,885 30 Sep 2025
13F
ARMISTICE CAPITAL, LLC
13D/G 13F
Company
6.7%
2,648,000
$40,382,000 +$6,283,000 31 Dec 2025
VANGUARD GROUP INC
13F
Company
5.8%
2,282,670
$33,418,289 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.7%
1,475,718
$21,604,512 30 Sep 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.9%
1,142,545
$16,725,596 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.4%
941,320
$13,783,917 30 Sep 2025
13F
Philosophy Capital Management LLC
13F
Company
2.2%
883,608
$12,936,021 30 Sep 2025
13F
STATE STREET CORP
13F
Company
2.2%
872,134
$12,768,042 30 Sep 2025
13F
AYAL Capital Advisors Ltd
13F
Company
2.1%
829,900
$12,149,736 30 Sep 2025
13F
Nuveen, LLC
13F
Company
1.4%
535,272
$7,836,382 30 Sep 2025
13F
Keith Valentine
3/4/5
President & CEO, Director
class O/S missing
377,741
$5,156,165 28 Feb 2023
NORTHERN TRUST CORP
13F
Company
0.87%
343,681
$5,031,490 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.85%
335,798
$4,916,083 30 Sep 2025
13F
Jon Carl Serbousek
3/4/5
Executive Chairman, Director
class O/S missing
346,827
$4,734,189 03 Apr 2023
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.78%
310,645
$4,547,843 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.75%
296,254
$4,337,158 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.72%
284,888
$4,170,761 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.65%
258,035
$3,777,632 30 Sep 2025
13F
GABELLI FUNDS LLC
13F
Company
0.59%
234,303
$3,430,196 30 Sep 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.55%
217,044
$3,177,524 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.53%
210,060
$3,075,278 30 Sep 2025
13F
Kimberley A. Elting
3/4/5
President, Global Orthopedics
mixed-class rows
271,614
mixed-class rows
$3,056,365 08 Jun 2024
Stuart Essig
3/4/5
Director
class O/S missing
205,966
$2,811,436 05 Jan 2023
Russell Investments Group, Ltd.
13F
Company
0.48%
189,734
$2,777,703 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.48%
189,122
$2,768,000 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.44%
172,405
$2,524,009 30 Sep 2025
13F
GAMCO INVESTORS, INC. ET AL
13F
Company
0.43%
171,800
$2,515,152 30 Sep 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.43%
170,363
$2,491,000 30 Sep 2025
13F
GREAT LAKES ADVISORS, LLC
13F
Company
0.42%
165,986
$2,430,035 30 Sep 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.37%
145,362
$2,128,100 30 Sep 2025
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.35%
140,239
$2,053,099 30 Sep 2025
13F
Kevin J. Kenny
3/4/5
President of Global Spine
class O/S missing
145,810
$1,990,307 08 Jan 2024
BARCLAYS PLC
13F
Company
0.34%
135,477
$1,983,382 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.29%
116,178
$1,700,853 30 Sep 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.29%
115,317
$1,688,241 30 Sep 2025
13F
UBS Group AG
13F
Company
0.28%
111,350
$1,630,164 30 Sep 2025
13F
Catherine M. Burzik
3/4/5
Director
class O/S missing
112,803
$1,605,187 08 Apr 2024
Rice Doug
3/4/5
CFO
class O/S missing
107,679
$1,469,818 11 Apr 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.24%
96,091
$1,406,772 30 Sep 2025
13F
HighVista Strategies LLC
13F
Company
0.24%
93,200
$1,364,448 30 Sep 2025
13F
John J. Bostjancic
3/4/5
CFO
class O/S missing
99,670
$1,360,496 28 Feb 2023
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.22%
87,064
$1,274,617 30 Sep 2025
13F
Squarepoint Ops LLC
13F
Company
0.22%
85,248
$1,248,031 30 Sep 2025
13F
FMR LLC
13F
Company
0.2%
80,380
$1,176,767 30 Sep 2025
13F
James F. Hinrichs.
3/4/5
Director
class O/S missing
86,153
$1,175,988 14 Sep 2023

Institutional Holders of Orthofix Medical Inc. - Common Stock (OFIX) as of Q4 2025

As of 31 Dec 2025, Orthofix Medical Inc. - Common Stock (OFIX) was held by 142 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,152,622 shares. The largest 10 holders included Engine Capital Management, LP, Rubric Capital Management LP, Juniper Investment Company, LLC, PARADIGM CAPITAL MANAGEMENT INC/NY, BlackRock, Inc., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Philosophy Capital Management LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 142 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
142
Q4 2025 holders
142
Holder diff
0
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.